Teva Pharmaceutical Industries has terminated its American Depositary Share (ADS) program and has begun trading its ordinary shares directly on the New York Stock Exchange (NYSE) as of September 14, 2026. The company's ticker symbol remains 'TEVA', simplifying the share structure for U.S. investors.
Key Details
- Listing Change: Effective September 14, 2026, Teva's ordinary shares began trading on the NYSE, replacing its previous American Depositary Shares (ADSs).
- ADS Exchange: The ADS program was terminated, with each ADS automatically exchanged for one ordinary share.
- Ticker Symbol: The company continues to trade under the ticker symbol 'TEVA' on both the NYSE and the Tel Aviv Stock Exchange.